Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $63.05 today, the market must believe free cash flow compounds 26.6%/yr for a decade (off $141M normalized FCF).
The market's 26.6% is more optimistic than its 9-yr track record.
2-stage DCF · 0.15B shares · net debt $1.6B
mean 4.9% · volatility σ 53% · implied rate exceeded in 3/9 yrs
Central path = implied 26.6%/yr growth; shaded band = ±1σ (53%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.44B 100.0% | $3.37B 100.0% | $2.96B 100.0% | $2.53B 100.0% | $2.42B 100.0% | $1.99B 100.0% | $2.07B 100.0% | $1.90B 100.0% | $1.77B 100.0% | $1.61B 100.0% |
| Cost of Revenue | $1.86B 54.1% | $1.72B 51.0% | $1.45B 49.0% | $1.23B 48.4% | $1.21B 50.0% | $1.05B 52.7% | $1.08B 52.0% | $995.6M 52.5% | $949.9M 53.8% | $866.0M 53.7% |
| Cost of Products | — | — | — | — | — | — | — | — | $790.7M 44.8% | $714.2M 44.3% |
| Cost of Services | — | — | — | — | — | — | — | — | $160.8M 9.1% | $150.0M 9.3% |
| Gross Profit | $1.58B 45.9% | $1.65B 49.0% | $1.51B 51.0% | $1.31B 51.6% | $1.21B 50.0% | $939.8M 47.3% | $995.3M 48.0% | $900.0M 47.5% | $816.0M 46.2% | $745.3M 46.3% |
| Research & Development | $395.2M 11.5% | $376.5M 11.2% | $294.8M 9.9% | $235.9M 9.3% | $220.8M 9.1% | $198.0M 10.0% | $187.7M 9.1% | $173.4M 9.1% | $161.6M 9.2% | $147.9M 9.2% |
| Selling, General & Admin | $946.5M 27.5% | $893.8M 26.6% | $729.4M 24.6% | $607.4M 24.0% | $561.2M 23.2% | $468.6M 23.6% | $500.2M 24.1% | $444.7M 23.5% | $415.2M 23.5% | $389.8M 24.2% |
| Total Operating Expenses | $1.51B 43.9% | $1.40B 41.5% | $1.08B 36.3% | $873.0M 34.5% | $796.3M 32.9% | $691.5M 34.8% | $694.4M 33.5% | $637.6M 33.6% | $596.5M 33.8% | $563.5M 35.0% |
| Operating Income | $68.2M 2.0% | $253.1M 7.5% | $436.9M 14.7% | $432.7M 17.1% | $413.3M 17.1% | $248.3M 12.5% | $300.9M 14.5% | $262.4M 13.8% | $219.5M 12.4% | $181.8M 11.3% |
| Interest Expense | $60.3M 1.8% | $47.9M 1.4% | $16.4M 0.6% | $16.1M 0.6% | $14.3M 0.6% | $14.4M 0.7% | $16.0M 0.8% | $12.6M 0.7% | $15.4M 0.9% | $13.2M 0.8% |
| Interest & Investment Income | $14.8M 0.4% | $9.3M 0.3% | $7.5M 0.3% | $2.8M 0.1% | $900K 0.0% | $3.2M 0.2% | $1.3M 0.1% | $1.2M 0.1% | $800K 0.0% | $300K 0.0% |
| Other Income (Expense), net | -$46.2M -1.3% | -$46.2M -1.4% | $107.3M 3.6% | -$18.8M -0.7% | -$19.7M -0.8% | -$22.5M -1.1% | -$20.5M -1.0% | -$17.7M -0.9% | -$21.7M -1.2% | -$4.2M -0.3% |
| Pretax Income | $22.0M 0.6% | $206.9M 6.1% | $544.2M 18.4% | $413.9M 16.4% | $393.6M 16.3% | $225.8M 11.4% | $280.4M 13.5% | $244.7M 12.9% | $197.8M 11.2% | $177.6M 11.0% |
| Income Tax Expense | $29.3M 0.9% | $91.4M 2.7% | $117.7M 4.0% | $116.4M 4.6% | $113.0M 4.7% | $64.4M 3.2% | $82.4M 4.0% | $63.7M 3.4% | $117.5M 6.7% | $23.1M 1.4% |
| Net Income | -$8.3M -0.2% | $113.8M 3.4% | $428.5M 14.5% | $298.5M 11.8% | $280.6M 11.6% | $157.8M 7.9% | $197.2M 9.5% | $179.7M 9.5% | $78.6M 4.5% | $153.6M 9.5% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.15 | $0.76 | $2.92 | $2.00 | $1.83 | $1.03 | $1.27 | $1.15 | $0.50 | $0.95 |
| EPS (Diluted) | $-0.15 | $0.76 | $2.90 | $1.99 | $1.81 | $1.02 | $1.26 | $1.14 | $0.49 | $0.95 |
| Weighted Avg Shares (Basic) | 151.8M | 149.0M | 146.4M | 149 | 151 | 153 | 155 | 156.2M | 158.1M | 161.4M |
| Weighted Avg Shares (Diluted) | 151.8M | 149.5M | 147.2M | 149 | 153 | 155 | 157 | 157.2M | 159.1M | 162.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 53% of free cash flow, leaving room to grow it and fund buybacks. Last year: $23M dividends + $10M buybacks = $33M returned on $43M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -0%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $299M covers the $12M due within a year 25.1× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~3.3% on $1.9B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 59th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 52.5 | 52.0 | 52.7 | 50.0 | 48.4 | 49.0 | 51.0 | 54.1 |
| Gross Profit | 47.5 | 48.0 | 47.3 | 50.0 | 51.6 | 51.0 | 49.0 | 45.9 |
| R&D | 9.1 | 9.1 | 10.0 | 9.1 | 9.3 | 9.9 | 11.2 | 11.5 |
| SG&A | 23.5 | 24.1 | 23.6 | 23.2 | 24.0 | 24.6 | 26.6 | 27.5 |
| Operating Income | 13.8 | 14.5 | 12.5 | 17.1 | 17.1 | 14.7 | 7.5 | 2.0 |
| Income Tax | 3.4 | 4.0 | 3.2 | 4.7 | 4.6 | 4.0 | 2.7 | 0.9 |
| Net Income | 9.5 | 9.5 | 7.9 | 11.6 | 11.8 | 14.5 | 3.4 | -0.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BRKR: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.